Skip to content
Calculator

Part of the skin and hair peptide hub: every topical and cosmetic peptide we cover, with its evidence grade.

Evidence: LowPeptide Research Only Cosmetic & Skin

Tripeptide-32

also known as: Chronolux, STP-NH2, Ser-Thr-Pro-NH2

STP-NH2, a cosmetic tripeptide sold with circadian-rhythm claims. PubMed holds no study of it.

Tripeptide-32 is a synthetic tripeptide amide, Ser-Thr-Pro-NH2 (PubChem lists it under its INCI name and the trade name Chronolux). It is sold with claims about skin's daily rhythm, but a title-and-abstract search of PubMed for its INCI name finds no study of it. It is not a drug.

No dosing data yet Details ↓

Mechanism of action

Not established: no published study describes its action.

Primary uses

Typical dosing

Not established for human use

No published study states an amount of this ingredient used on skin, and a supplier's use level is not a source on this site, so none is given.

Regulatory status

Not a drug: PubChem lists it under its INCI name as a cosmetic ingredient (CID 44200646). Drugs@FDA and the EMA medicines list hold no record for it (searched October 28, 2026).

Status as of this entry's last review, October 28, 2026. Approvals, compounding rules and sport rules change; the regulatory tracker is checked more often.

What we checked

Tripeptide-32 is a cosmetic peptide ingredient with little or no published literature; this section records what can be checked.

Identity, computed

SequenceSer-Thr-Pro-NH2 (STP-NH2)
FormulaC12H22N4O5
Average mass302.33 g/mol
Monoisotopic mass302.159 Da
Isoelectric pointnone between pH 0 and 14: no acidic group, so the peptide stays positive (net charge +0.98 at pH 7)

The sequence is the one PubChem's record gives for the INCI ingredient; the values below are computed and agree with PubChem's formula.

Regulatory status, read October 29, 2026

Drugs@FDA: 0 records for “tripeptide-32”. EMA medicines list: 0 records for “tripeptide-32”. Run for semaglutide, the same queries return 6 and 5 records (and the registry search 81 trials), so a zero here is an absence, not a broken search. Not named on the WADA 2026 and 2027 Prohibited Lists. As a substance with no current approval for human therapeutic use, it falls under section S0 (non-approved substances), which is prohibited at all times; the lists were read on October 28, 2026.

What we looked for and did not find

No published study of any kind, no registry record and no drug approval.

SourceQueryResults, October 29, 2026What it was
PubMed("tripeptide-32"[tiab])0name matched word by word in title/abstract (a phrase search misses hyphen-numbered names)
ClinicalTrials.govtripeptide-320
Drugs@FDA (openFDA)tripeptide-320
EMA medicines listtripeptide-320

References

  1. [other] PubChem CID 44200646, Tripeptide-32: formula C12H22N4O5, molecular weight 302.3. Read October 28, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/44200646

Related peptides

Guides & tools

Disclaimer

This entry is for educational purposes only and does not constitute medical advice. Dosing information reflects published regulatory or research data and is not a recommendation. Many compounds described here are not approved for human use in the United States. Consult a licensed medical professional before considering any peptide therapy.